Ignite Creation Date:
2024-05-05 @ 12:00 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00201734
Status:
TERMINATED
Last Update Posted:
2016-09-23
First Post:
2005-09-12
Brief Title:
Capecitabine Carboplatin and Weekly Paclitaxel for Patients With Solid Tumors and Adenocarcinoma of Unknown Primary
Sponsor:
Ohio State University Comprehensive Cancer Center
Organization:
Ohio State University Comprehensive Cancer Center
Organization Data
Organization:
Ohio State University Comprehensive Cancer Center
Class:
OTHER
Study ID:
OSU-0317
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Ohio State University Comprehensive Cancer Center
Lead Sponsor Class:
OTHER
Responsible Party:
Tony Bekaii-Saab
Responsible Party Title:
Principal Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Ohio State University Comprehensive Cancer Center
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Roche Pharma AG | INDUSTRY |